CytomX Therapeutics, Inc. isamba semali engenayo, imali engenayo yonke kanye nezinguquko zezinguquko eziguqwini US dollar namuhla
Imali engenayo CytomX Therapeutics, Inc. manje 15 971 000 $. Imininingwane mayelana nemali engenayo ithathwa emithonjeni evulekile. Amandla we- CytomX Therapeutics, Inc. yehle ngo- -402 000 $ kusukela ngesikhathi sokubika sokugcina. Nazi izinkomba eziphambili zezezimali ze- CytomX Therapeutics, Inc.. Igrafu yezezimali ye- CytomX Therapeutics, Inc. ikhombisa amanani nezinguquko zezinkomba ezinjalo: impahla ephelele, imali engenayo, imali engenayo. Isheduli yemibiko yezezimali isuka ku- 30/06/2017 kuya ku- 31/03/2021 iyatholakala online. Yonke imininingwane esezingeni le- CytomX Therapeutics, Inc. isamba semali etholakala kuleli shadi lenziwa ngendlela yamabha aphuzi.
|
|
Usuku lokubika
|
Ingqikithi yenzuzo
Imali engenayo ibalwa ngokuphindaphinda ubuningi bezimpahla ezithengiswa ngentengo yezimpahla.
futhi
Ushintsho (%)
Ukuqhathaniswa kombiko wesinekota walo nyaka kanye nombiko wekota wonyaka odlule.
|
Imali engenayo
Imali engenayo iyinzuzo yebhizinisi ngaphandle kwezindleko zezimpahla ezithengisiwe, izindleko nezintela esikhathini sokubika.
futhi
Ushintsho (%)
Ukuqhathaniswa kombiko wesinekota walo nyaka kanye nombiko wekota wonyaka odlule.
|
|
31/03/2021 |
15 971 000 $ |
-45.833 % ↓ |
-15 554 000 $ |
- |
|
31/12/2020 |
16 373 000 $ |
+42.73 % ↑ |
-14 701 000 $ |
- |
|
30/09/2020 |
17 788 000 $ |
+66.06 % ↑ |
-14 710 000 $ |
- |
|
30/06/2020 |
16 608 000 $ |
+84.27 % ↑ |
-15 679 000 $ |
- |
|
30/09/2019 |
10 712 000 $ |
-
|
-23 699 000 $ |
-
|
|
30/06/2019 |
9 013 000 $ |
-
|
-28 960 000 $ |
-
|
|
31/03/2019 |
29 485 000 $ |
-
|
-14 124 000 $ |
-
|
|
31/12/2018 |
11 471 000 $ |
-
|
-32 233 000 $ |
-
|
|
30/09/2018 |
12 509 000 $ |
-
|
-23 431 000 $ |
-
|
|
30/06/2018 |
21 338 000 $ |
-
|
-13 447 000 $ |
-
|
|
31/03/2018 |
14 184 000 $ |
-
|
-15 493 000 $ |
-
|
|
31/12/2017 |
27 073 000 $ |
-
|
621 000 $ |
-
|
|
30/09/2017 |
24 144 000 $ |
-
|
-10 247 000 $ |
-
|
|
30/06/2017 |
8 752 000 $ |
-
|
-25 216 000 $ |
-
|
|
|
Bonisa:
|
|
Ukuze
|
|
|
|
Umbiko wezezimali CytomX Therapeutics, Inc., isimiso
Izinsuku zezitatimende zezimali zakamuva ze- CytomX Therapeutics, Inc.: 30/06/2017, 31/12/2020, 31/03/2021. Izinsuku zezitatimende zezezimali zinqunywa yimithetho yokubalwa kwezimali. Usuku lwakamuva lombiko wezezimali we CytomX Therapeutics, Inc. yi 31/03/2021. Imali engenayo yokusebenza CytomX Therapeutics, Inc. iyisilinganiso sokuphendula esilinganisa inani lemali etholakalayo emisebenzini yebhizinisi, ngemuva kokunciphisa izindleko zokusebenza, njengeholo, ukwehla kwenani kanye nezindleko zezimpahla ezithengiswayo. Imali engenayo yokusebenza CytomX Therapeutics, Inc. kuyinto -15 627 000 $
|
|
|
Izinsuku zembiko yezimali CytomX Therapeutics, Inc.
Imali engenayo CytomX Therapeutics, Inc. iyinzuzo yebhizinisi ngaphandle kwezindleko zezimpahla ezithengisiwe, izindleko nezintela esikhathini sokubika. Imali engenayo CytomX Therapeutics, Inc. kuyinto -15 554 000 $ Izindleko zokusebenza CytomX Therapeutics, Inc. yizindleko ibhizinisi elizibandakanya ngenxa yokwenza imisebenzi yalo evamile yebhizinisi. Izindleko zokusebenza CytomX Therapeutics, Inc. kuyinto 31 598 000 $ Imali yamanje CytomX Therapeutics, Inc. yimali yonke imali egcinwe yinkampani ngosuku lombiko. Imali yamanje CytomX Therapeutics, Inc. kuyinto 329 666 000 $
|
|
Ukulingana CytomX Therapeutics, Inc. yinani lazo zonke izimpahla zomnikazi ngemuva kokukhipha izikweletu eziphelele kumpahla ephelele. Ukulingana CytomX Therapeutics, Inc. kuyinto 146 022 000 $
|
|
31/03/2021
|
31/12/2020
|
30/09/2020
|
30/06/2020
|
30/09/2019
|
30/06/2019
|
31/03/2019
|
31/12/2018
|
30/09/2018
|
30/06/2018
|
31/03/2018
|
31/12/2017
|
30/09/2017
|
30/06/2017
|
|
|
Inzuzo enkulu
Inzuzo eyinzuzo yinzuzo eyenziwa yinkampani ngemuva kokunciphisa izindleko zokukhiqiza nokuthengisa imikhiqizo yayo kanye / noma izindleko zokuhlinzeka ngezinsizakalo zayo.
|
15 971 000 $ |
16 373 000 $ |
17 788 000 $ |
16 608 000 $ |
10 712 000 $ |
9 013 000 $ |
29 485 000 $ |
11 471 000 $ |
- |
- |
- |
- |
- |
- |
|
Inani lentengo
Izindleko yizindleko eziphelele zokukhiqizwa nokusatshalaliswa kwemikhiqizo namasevisi yenkampani.
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Ingqikithi yenzuzo
Imali engenayo ibalwa ngokuphindaphinda ubuningi bezimpahla ezithengiswa ngentengo yezimpahla.
|
15 971 000 $ |
16 373 000 $ |
17 788 000 $ |
16 608 000 $ |
10 712 000 $ |
9 013 000 $ |
29 485 000 $ |
11 471 000 $ |
12 509 000 $ |
21 338 000 $ |
14 184 000 $ |
27 073 000 $ |
24 144 000 $ |
8 752 000 $ |
|
Imali engenayo yokusebenza
Imali engenayo yokusebenza iyinzuzo evela ebhizinisini lenhloko yenkampani. Isibonelo, umthengisi udala imali engenayo ngokusebenzisa ukudayiswa kwezimpahla, kanti udokotela uthola inzuzo emisebenzini yezokwelapha ayinikezayo.
|
- |
- |
- |
- |
10 712 000 $ |
9 013 000 $ |
29 485 000 $ |
11 471 000 $ |
12 509 000 $ |
21 338 000 $ |
14 184 000 $ |
27 073 000 $ |
24 144 000 $ |
8 752 000 $ |
|
Imali engenayo yokusebenza
Imali engenayo yokusebenza iyisilinganiso sokuphendula esilinganisa inani lemali etholakalayo emisebenzini yebhizinisi, ngemuva kokunciphisa izindleko zokusebenza, njengeholo, ukwehla kwenani kanye nezindleko zezimpahla ezithengiswayo.
|
-15 627 000 $ |
-14 779 000 $ |
-14 895 000 $ |
-16 138 000 $ |
-25 718 000 $ |
-31 233 000 $ |
-16 565 000 $ |
-25 810 000 $ |
-23 177 000 $ |
-13 257 000 $ |
-15 630 000 $ |
-1 247 000 $ |
-11 025 000 $ |
-25 373 000 $ |
|
Imali engenayo
Imali engenayo iyinzuzo yebhizinisi ngaphandle kwezindleko zezimpahla ezithengisiwe, izindleko nezintela esikhathini sokubika.
|
-15 554 000 $ |
-14 701 000 $ |
-14 710 000 $ |
-15 679 000 $ |
-23 699 000 $ |
-28 960 000 $ |
-14 124 000 $ |
-32 233 000 $ |
-23 431 000 $ |
-13 447 000 $ |
-15 493 000 $ |
621 000 $ |
-10 247 000 $ |
-25 216 000 $ |
|
Izindleko ze-R & D
Izindleko zokucwaninga nezentuthuko - izindleko zocwaningo zokuthuthukisa imikhiqizo nezinqubo ezikhona noma ukuthuthukisa imikhiqizo nezinqubo ezintsha.
|
22 371 000 $ |
22 007 000 $ |
24 049 000 $ |
24 066 000 $ |
27 967 000 $ |
30 835 000 $ |
36 376 000 $ |
28 306 000 $ |
27 549 000 $ |
25 553 000 $ |
22 458 000 $ |
20 704 000 $ |
28 920 000 $ |
28 076 000 $ |
|
Izindleko zokusebenza
Izindleko zokusebenza yizindleko ibhizinisi elizibandakanya ngenxa yokwenza imisebenzi yalo evamile yebhizinisi.
|
31 598 000 $ |
31 152 000 $ |
32 683 000 $ |
32 746 000 $ |
36 430 000 $ |
40 246 000 $ |
46 050 000 $ |
37 281 000 $ |
35 686 000 $ |
34 595 000 $ |
29 814 000 $ |
28 320 000 $ |
35 169 000 $ |
34 125 000 $ |
|
Amafa wamanje
Izimpahla zamanje ziyingxenye yebhalansi emela ukubaluleka kwazo zonke izimpahla ezingashintshwa zibe yikheshi phakathi nonyaka owodwa.
|
400 008 000 $ |
324 013 000 $ |
340 305 000 $ |
366 566 000 $ |
334 778 000 $ |
366 677 000 $ |
405 077 000 $ |
445 475 000 $ |
472 508 000 $ |
366 671 000 $ |
367 031 000 $ |
388 601 000 $ |
376 374 000 $ |
340 680 000 $ |
|
Inani lempahla
Ingqikithi yempahla iyinani elilingana nengqikithi yenani eliphelele lenhlangano, amanothi esikweletu, nempahla ebonakalayo.
|
434 158 000 $ |
358 663 000 $ |
375 182 000 $ |
402 479 000 $ |
372 544 000 $ |
405 284 000 $ |
444 513 000 $ |
457 108 000 $ |
482 726 000 $ |
376 942 000 $ |
376 462 000 $ |
397 644 000 $ |
387 039 000 $ |
351 855 000 $ |
|
Imali yamanje
Imali yamanje yimali yonke imali egcinwe yinkampani ngosuku lombiko.
|
329 666 000 $ |
191 859 000 $ |
176 810 000 $ |
291 388 000 $ |
164 646 000 $ |
149 392 000 $ |
190 407 000 $ |
247 577 000 $ |
260 670 000 $ |
133 825 000 $ |
143 072 000 $ |
177 548 000 $ |
284 225 000 $ |
272 860 000 $ |
|
Isikweletu samanje
Isikweletu samanje siyingxenye yesikweletu esikhokhwa phakathi nonyaka (izinyanga ezingu-12) futhi siboniswa njengesibophezelo samanje kanye nengxenye yenani elisebenzayo.
|
- |
- |
- |
- |
76 126 000 $ |
78 673 000 $ |
96 217 000 $ |
97 908 000 $ |
- |
- |
- |
- |
- |
- |
|
Inani lemali
Ingqikithi yenkokhelo yinani lazo zonke imali enkampani enayo kuma-akhawunti ayo, kufaka phakathi imali encane nemali ebanjwe ebhange.
|
- |
- |
- |
- |
- |
- |
- |
- |
464 562 000 $ |
335 146 000 $ |
361 476 000 $ |
374 110 000 $ |
331 275 000 $ |
335 916 000 $ |
|
Isikweletu sonke
Ingqikithi yesikweletu iyinhlanganisela yesikweletu sesikhashana nesikhathi eside. Izikweleti zesikhashana esifushane yizo okufanele zibuyiselwe phakathi nonyaka. Isikweletu sesikhathi eside sihlanganisa zonke izikweletu okufanele zibuyiselwe ngemuva konyaka owodwa.
|
- |
- |
- |
- |
290 435 000 $ |
303 783 000 $ |
321 942 000 $ |
326 225 000 $ |
- |
- |
- |
- |
- |
- |
|
Isikweletu sesilinganiso
Ingqikithi yesamba semali ephelele yezimpahla yi-ratio yezezimali ekhombisa iphesenti yezimpahla zenkampani ezimele njengesikweletu.
|
- |
- |
- |
- |
77.96 % |
74.96 % |
72.43 % |
71.37 % |
- |
- |
- |
- |
- |
- |
|
Ukulingana
Ukulingana yinani lazo zonke izimpahla zomnikazi ngemuva kokukhipha izikweletu eziphelele kumpahla ephelele.
|
146 022 000 $ |
49 803 000 $ |
48 064 000 $ |
58 829 000 $ |
82 109 000 $ |
101 501 000 $ |
122 571 000 $ |
130 883 000 $ |
157 661 000 $ |
41 133 000 $ |
49 647 000 $ |
69 896 000 $ |
45 479 000 $ |
52 237 000 $ |
|
Ukugeleza kwemali
Ukugeleza kwezimali kuyinani eliphelele lemali kanye nezilinganiso zemali ezihamba enhlanganweni.
|
- |
- |
- |
- |
-23 319 000 $ |
-48 653 000 $ |
-39 029 000 $ |
-28 742 000 $ |
-5 551 000 $ |
-26 616 000 $ |
-14 612 000 $ |
22 002 000 $ |
-5 738 000 $ |
173 195 000 $ |
|
|
Umbiko wamuva wezezimali ngemali engenayo CytomX Therapeutics, Inc. kwakungu-31/03/2021. Ngokombiko wamuva ngemiphumela yezezimali ye-CytomX Therapeutics, Inc., imali engenayo ye-CytomX Therapeutics, Inc. yayingu-15 971 000 US dollar futhi ishintshwe yaba ngu--45.833% uma kuqhathaniswa nonyaka odlule. Inzuzo enenetha ye CytomX Therapeutics, Inc. engxenyeni yokugcina yayingu--15 554 000 $, inzuzo enenzuzo ishintshwe ngu-0% uma kuqhathaniswa nonyaka odlule.
|
